Retension Pharmaceuticals prices IPO at $12 per share on Nasdaq
Retension Pharmaceuticals prices IPO at $12 per share on Nasdaq
Not thousands of headlines. The few lines that move price. For traders: straight from the source, clear and simple.
Retension Pharmaceuticals prices IPO at $12 per share on Nasdaq
Retension Pharmaceuticals prices IPO at $12 per share on Nasdaq
Halozyme CEO Helen Torley sells $6.61m in shares
The review is aimed as much at bond investors as at the budget, since concern over how Takaichi’s pledges will be funded has pushed 10-year JGB yields to multi-decade highs. Credible savings that cap new debt issuance near 40 trillion yen could ease some fiscal risk premium in long-dated JGBs and lend modest support to the yen. However, the first round’s thin results leave markets likely to wait…
Euro skids toward fifth weekly fall but selling pressure slows
SoftBank shares slide as OpenAI revenue report dents AI optimism
Japan Post Holdings, a 10% owner, sells $1.48m in AFLAC shares
SpaceX plans to purchase Grain Management’s 800 MHz spectrum portfolio in a move to bolster its mobile ambitions. The news is lifting cell-tower stocks.
Hitachi joins Anthropic cybersecurity program
Japan reboots DOGE-style spending review in hunt for funds for Takaichi pledges
The letter follows a report by the Democratic investigators last month alleging Tether’s USDT has become a key tool for Iran’s shadow banking network.
Crowdstrike CEO George Kurtz sells $5.49m in stock on Oct. 6-7
U.S. stock futures steady after Nasdaq slides on OpenAI revenue concerns
The circa 5.5% drop in Oracle shares shows investors are sensitive to any sign that power constraints could delay AI capacity and push out the timeline for its free cash flow to turn positive. The force majeure notice on Project Jupiter raises the risk of disputes and delays at one of its most important sites. For natural gas, data centre demand is becoming a meaningful new source of consumption,…
US sued over plan to blast Utah canyon inscribed by 19th century ’Buffalo Soldiers,’ European pioneers
Vistra EVP and CFO Kristopher Moldovan sells $3.3m in stock
The mixed readings are unlikely to shift Bank of Japan rate expectations decisively in either direction, limiting the immediate impact on the yen and Japanese government bonds. A smaller annual decline offers modest support to the case for tightening, but the weak monthly gain and nine straight contractions undercut the argument that consumption is recovering alongside wages. That gap between…
Nvidia plans to invest in AI chip rival d-Matrix- The Information
Park Aerospace earnings beat by $0.12, revenue topped estimates
Exclusive-AI surveillance startup Flock Safety to cut several hundred jobs amid backlash, sources say
News text belongs to its source; only the headline and a short summary appear here.